Embecta Corp. provided earnings guidance for the fiscal year 2024. For the year, the company expects revenues to be $1,111 million -$1,116 million against previous guidance of $1,094 million- $1,116 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.45 USD | +1.76% | +1.47% | -23.67% |
May. 16 | Transcript : Embecta Corp. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM | |
May. 09 | Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.67% | 833M | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+6.67% | 42.73B | |
+25.54% | 32.52B | |
+20.03% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- EMBC Stock
- News Embecta Corp.
- Embecta Corp. Provides Earnings Guidance for the Fiscal Year 2024